Updated Jul 16, 2026
SMITH SCOTT THOMAS has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $78K.
Scott Thomas Smith appears in SEC filings related to Ascendis Pharma A/S as of 2026-06-01. In the provided SEC context, there are no publicly documented biographical details, specific role titles, or notable achievements for this individual. The connection to Ascendis Pharma A/S is not accompanied by verifiable background information within the given data.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | ASND | Ascendis Pharma A/S | P — Open-market purchase | 100 | $219.00 | $22K |
| 2026-06-01 | ASND | Ascendis Pharma A/S | P — Open-market purchase | 250 | $223.32 | $56K |
Scott Thomas Smith appears in SEC filings related to Ascendis Pharma A/S as of 2026-06-01. In the provided SEC context, there are no publicly documented biographical details, specific role titles, or notable achievements for this individual. The connection to Ascendis Pharma A/S is not accompanied by verifiable background information within the given data.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 2 open-market purchases ($78K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SMITH SCOTT THOMAS profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.